Lupin Earns Great Place To Work® India 2026 Nation Builders Recognition
Lupin Limited (Lupin) announced that it has been recognized among India's Best Employers in the Nation-Builders Category 2026 by Great Place To Work® India, ranking...
Eli Lilly Acquires AtaiBeckley to Accelerate Innovative Depression Treatments
Eli Lilly and Company and AtaiBeckley Inc. announced a agreement for Lilly to acquire AtaiBeckley. The transaction features cash consideration of $6.75 per share,...
AstraZeneca Licenses Novel Lung Cancer Drug Zegfrovy in $1.5B Global Deal
AstraZeneca announced a exclusive global license agreement with Dizal Pharmaceutical to develop and commercialize Zegfrovy (sunvozertinib), a highly differentiated, oral irreversible EGFR inhibitor designed for targeted lung cancer...
VerGo Pharma Successfully Concludes Unannounced US FDA Inspection with Zero Observations
VerGo Pharma, a leading Contract Research Organization (CRO), announced the successful completion of an unannounced United States Food and Drug Administration (US FDA) inspection at...
Warburg Pincus Acquires Integrace Private Ltd for ₹1,000 Crore
Global private equity firm Warburg Pincus has successfully completed the acquisition of domestic pharmaceuticals company Integrace Private Ltd from existing shareholders True North and Temasek. While official financial details...
Dr. Reddy’s Announces First-to-Market Launch of Generic Bosulif®️ Tablets in the U.S.
Dr. Reddy’s Laboratories Ltd. has launched Bosutinib Tablets 400mg, a first-to-market generic equivalent of Wyeth LLC’s Bosulif®, in the United States. As a first-to-file product,...